Dr Reddys Laboratories Share Price Today - Live Blog for April 16, 2025

The stock of Dr Reddys Laboratories Ltd is facing a -0.47% decline and is currently trading at ₹1,153.30 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd's share price has fallen by -0.14%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,157.80, and market participants are assessing the implications. The stock has a PE ratio of 17.9600, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd observed a -0.19% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,157.85. The stock has a PE ratio of 17.9600, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.26% increase. Presently, it is actively trading at ₹1,160.00.

The share price of Dr Reddys Laboratories Ltd experienced a -0.16% slump and is currently trading at ₹1,157.00. While the stock maintains a PE ratio of 17.9600, the industry PE is 32.7985, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.50%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,160.75 per share.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.11%, with its current market value per share resting at ₹1,153.50. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.10%, reaching the current market price of ₹1,151.20. This development underscores the stock's growing popularity.

The stock of Dr Reddys Laboratories Ltd suffered a -0.09% drop, and it's now trading at ₹1,150.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The stock of Dr Reddys Laboratories Ltd suffered a -0.11% decline, and it currently trades at ₹1,151.40 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock of Dr Reddys Laboratories Ltd suffered a -0.27% drop, and it's now trading at ₹1,150.70 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Following a noteworthy 0.36% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,153.00. When it comes to valuation, this stock has a PE ratio of 17.9600, with the industry PE ratio at 32.7985.

Dr Reddys Laboratories Ltd witnessed a -0.19% decrease in its share price, and it is currently trading at ₹1,147.95. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.9600, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd experienced a substantial 0.10% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,150.50, making it an appealing option for investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.10% drop, and it's now trading at ₹1,150.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.37% uptick in its share price. As a result, it's now actively trading at ₹1,150.65 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd shares saw a -0.43% decrease, reaching a current market price of ₹1,145.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.9600, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The share price of Dr Reddys Laboratories Ltd experienced a -0.03% slump and is currently trading at ₹1,150.95. While the stock maintains a PE ratio of 17.9600, the industry PE is 32.7985, raising questions about valuation.

Dr Reddys Laboratories Ltd witnessed a notable 0.05% surge in its share price and is presently trading at ₹1,150.05, captivating the attention of market participants.

The share price of Dr Reddys Laboratories Ltd experienced a -0.05% slump and is currently trading at ₹1,149.50. While the stock maintains a PE ratio of 17.9600, the industry PE is 32.7985, raising questions about valuation.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.24% increase and currently trading at ₹1,150.00 per share. Investors are taking notice of this upward momentum.

The share price of Dr Reddys Laboratories Ltd experienced a -0.29% slump and is currently trading at ₹1,147.20. While the stock maintains a PE ratio of 17.9600, the industry PE is 32.7985, raising questions about valuation.

The stock of Dr Reddys Laboratories Ltd suffered a -0.18% decline, and it currently trades at ₹1,150.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

With a -0.38% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,150.60. This development raises questions about the factors behind the decline. The stock's PE ratio is 17.9600, while the industry PE is 32.7985.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.65% uptick in its share price. As a result, it's now actively trading at ₹1,156.00 per share, making it an attractive option for investors.

The share price of Dr Reddys Laboratories Ltd plunged by -0.93%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,149.25, but investors are assessing whether this is a temporary dip or a long-term trend.